4.7 Review

Hepatocyte transplantation for inherited metabolic diseases of the liver

期刊

JOURNAL OF INTERNAL MEDICINE
卷 272, 期 3, 页码 201-223

出版社

WILEY
DOI: 10.1111/j.1365-2796.2012.02574.x

关键词

experimental; hepatology; liver; surgery; transplantation immunology; a-1-antitrypsin deficiency

资金

  1. Research Strategy Committee Karolinska Institute
  2. Stockholm County Council (Forskar ST)
  3. Stockholm County Council
  4. Karolinska Institutet

向作者/读者索取更多资源

Inherited metabolic diseases of the liver are characterized by deficiency of a hepatic enzyme or protein often resulting in life-threatening disease. The remaining liver function is usually normal. For most patients, treatment consists of supportive therapy, and the only curative option is liver transplantation. Hepatocyte transplantation is a promising therapy for patients with inherited metabolic liver diseases, which offers a less invasive and fully reversible approach. Procedure-related complications are rare. Here, we review the experience of hepatocyte transplantation for metabolic liver diseases and discuss the major obstacles that need to be overcome to establish hepatocyte transplantation as a reliable treatment option in the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据